Live Breaking News & Updates on Early Drug Development Phase

Stay updated with breaking news from Early drug development phase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Crystal Denlinger Named Chief Scientific Officer for National Comprehensive Cancer Network


Crystal Denlinger Named Chief Scientific Officer for National Comprehensive Cancer Network
PLYMOUTH MEETING, Pa., Jan. 14, 2021 /PRNewswire/ The National Comprehensive Cancer Network
(NCCN
)-an alliance of leading cancer centers-today announced the appointment of
Crystal S. Denlinger, MD, FACP, to the newly-created role of Senior Vice President, Chief Scientific Officer. In this position, Dr. Denlinger will help to steer strategic direction for the nonprofit as well as oversee the NCCN Oncology Research Program (ORP). Her duties will also involve providing input into NCCN s clinical information program, including the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines
), as well as various continuing education activities. ....

Fox Chase , New Jersey , United States , Rachel Darwin , Robertw Carlson , Facebook Nccnorg , Instagram Nccnorg , Esophageal Gastric Cancers Panel , American Society Of Clinical Oncology , College Of New Jersey , Early Drug Development Phase , Oncology Research Program , Survivorship Program , American College Of Physicians , National Comprehensive Cancer Network Editorial Board , Guidelines Panel For Survivorship , Mount Sinai Medical Center , Fox Chase Cancer Center Temple University Hospital , Rutgers New Jersey Medical School , Fox Chase Cancer Center , National Comprehensive Cancer Network , Department Of Hematology Oncology , Senior Vice President , Chief Scientific , Research Program , Practice Guidelines ,